These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10989777)

  • 1. Ultra rapid opiate detoxification as compared to 30-day inpatient detoxification program--a retrospective follow-up study.
    Lawental E
    J Subst Abuse; 2000; 11(2):173-81. PubMed ID: 10989777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results.
    Bochud Tornay C; Favrat B; Monnat M; Daeppen JB; Schnyder C; Bertschy G; Besson J
    Drug Alcohol Depend; 2003 Apr; 69(3):283-8. PubMed ID: 12633914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of naltrexone maintenance following ultra rapid opiate detoxification versus intensive inpatient detoxification.
    Rabinowitz J; Cohen H; Atias S
    Am J Addict; 2002; 11(1):52-6. PubMed ID: 11876583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results.
    Cucchia AT; Monnat M; Spagnoli J; Ferrero F; Bertschy G
    Drug Alcohol Depend; 1998 Nov; 52(3):243-50. PubMed ID: 9839150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
    Foster J; Brewer C; Steele T
    Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
    Buntwal N; Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program.
    Reece AS
    Subst Abuse Treat Prev Policy; 2007 Nov; 2():35. PubMed ID: 18036213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid opiate detoxification.
    Bartter T; Gooberman LL
    Am J Drug Alcohol Abuse; 1996 Nov; 22(4):489-95. PubMed ID: 8911587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of ultrarapid opiate detoxification combined with naltrexone maintenance and counseling.
    Rabinowitz J; Cohen H; Kotler M
    Psychiatr Serv; 1998 Jun; 49(6):831-3. PubMed ID: 9634168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serendipitous rapid detoxification from opiates: the importance of time-dependent processes.
    Mannelli P; De Risio S; Pozzi G; Janiri L; De Giacomo M
    Addiction; 1999 Apr; 94(4):589-91. PubMed ID: 10605854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
    Grüsser SM; Thalemann CN; Platz W; Gölz J; Partecke G
    Biol Psychol; 2006 Mar; 71(3):231-5. PubMed ID: 16046046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation.
    Legarda JJ; Gossop M
    Drug Alcohol Depend; 1994 Apr; 35(2):91-3. PubMed ID: 8055740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term relapse of ultra-rapid opioid detoxification.
    Salimi A; Safari F; Mohajerani SA; Hashemian M; Kolahi AA; Mottaghi K
    J Addict Dis; 2014; 33(1):33-40. PubMed ID: 24471478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting depot formulations of naltrexone for heroin dependence: a review.
    Krupitsky EM; Blokhina EA
    Curr Opin Psychiatry; 2010 May; 23(3):210-4. PubMed ID: 20224403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study.
    Rabinowitz J; Cohen H; Tarrasch R; Kotler M
    Drug Alcohol Depend; 1997 Aug; 47(2):77-86. PubMed ID: 9298329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
    Hensel M; Kox WJ
    Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin.
    Sullivan MA; Vosburg SK; Comer SD
    Psychopharmacology (Berl); 2006 Nov; 189(1):37-46. PubMed ID: 16972105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
    Gerra G; Zaimovic A; Rustichelli P; Fontanesi B; Zambelli U; Timpano M; Bocchi C; Delsignore R
    J Subst Abuse Treat; 2000 Mar; 18(2):185-91. PubMed ID: 10716102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and ultrarapid opioid detoxification techniques.
    O'Connor PG; Kosten TR
    JAMA; 1998 Jan; 279(3):229-34. PubMed ID: 9438745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.